Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease.

Simple item page
dc.contributor.authorRey, M.
dc.contributor.authorYang, M.L.
dc.contributor.authorLee, L.
dc.contributor.authorZhang, Y.
dc.contributor.authorSheff, J.G.
dc.contributor.authorSensen, C.W.
dc.contributor.authorMrazek, H.
dc.contributor.authorHalada, P.
dc.contributor.authorMan, P.
dc.contributor.authorMcCarville, J.L.
dc.contributor.authorVerdu, E.F.
dc.contributor.authorSchriemer, David C.
dc.date.accessioned2017-06-01T18:46:03Z
dc.date.available2017-06-01T18:46:03Z
dc.date.issued2016-8-2
dc.description.abstractCeliac disease is triggered by partially digested gluten proteins. Enzyme therapies that complete protein digestion in vivo could support a gluten-free diet, but the barrier to completeness is high. Current options require enzyme amounts on the same order as the protein meal itself. In this study, we evaluated proteolytic components of the carnivorous pitcher plant (Nepenthes spp.) for use in this context. Remarkably low doses enhance gliadin solubilization rates, and degrade gliadin slurries within the pH and temporal constraints of human gastric digestion. Potencies in excess of 1200:1 (substrate-to-enzyme) are achieved. Digestion generates small peptides through nepenthesin and neprosin, the latter a novel enzyme defining a previously-unknown class of prolyl endoprotease. The digests also exhibit reduced TG2 conversion rates in the immunogenic regions of gliadin, providing a twin mechanism for evading T-cell recognition. When sensitized and dosed with enzyme-treated gliadin, NOD/DQ8 mice did not show intestinal inflammation, when compared to mice challenged with only pepsin-treated gliadin. The low enzyme load needed for effective digestion suggests that gluten detoxification can be achieved in a meal setting, using metered dosing based on meal size. We demonstrate this by showing efficient antigen processing at total substrate-to-enzyme ratios exceeding 12,000:1.en_US
dc.description.refereedYes
dc.description.sponsorshipThis work was supported by the University of Calgary and by a grant to DCS from the Canadian Celiac Association. EFV holds a Canada Research Chair and is funded by CIHR MOP#142773. PM, HM and PH were supported by MEYS (LO1509) and EU (CZ.1.05/1.1.00/02.0109). We thank Drs. Chella David and Joseph Murray of the Mayo Clinic for kindly providing the original breeding pairs of SPF NOD AB?DQ8 (NOD/DQ8) mice. We thank Luppo Edens of DSM Food Specialties (Netherlands) for the gift of AN-PEP. We thank Brent Schriemer, Laurent Brechenmacher and the Urban Bog for technical support.en_US
dc.identifier.citationRey, M., Yang, M., Lee, L., Zhang, Y., Sheff, J. G., Sensen, C. W., . . . Schriemer, D. C. (2016). Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. Scientific Reports, 6, 30980. doi:10.1038/srep30980en_US
dc.identifier.doi10.1038/srep30980
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/33772
dc.identifier.grantnumberMOP#142773
dc.identifier.grantnumberLO1509
dc.identifier.issn2045-2322en_US
dc.identifier.urihttp://hdl.handle.net/1880/52005
dc.language.isoenen_US
dc.publisherScientific Reports
dc.publisher.departmentMicrobiology & Infectious Diseases
dc.publisher.facultyCumming School of Medicine
dc.publisher.institutionUniversity of Calgaryen_US
dc.publisher.urlhttps://www.nature.com/srep/en_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCoeliac disease
dc.subjectProteases
dc.titleAddressing proteolytic efficiency in enzymatic degradation therapy for celiac disease.
dc.typejournal article
thesis.degree.disciplineBiochemistry
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
srep30980.pdf
Size:
1.52 MB
Format:
Adobe Portable Document Format
Description:
Main article
Download
Thumbnail Image
Name:
srep30980-s1.pdf
Size:
3.11 MB
Format:
Adobe Portable Document Format
Description:
Supplementary information
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.95 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Cumming School of Medicine Research & Publications